(77 days)
Not Found
No
The device description details a standard ultrasonic measurement process based on time intervals of reflected pulses, with no mention of AI or ML algorithms for data processing or interpretation.
No.
The device is used to measure anatomical dimensions (e.g., axial length, anterior chamber depth, corneal thickness) of the eye, which are diagnostic measurements for ophthalmology, not for therapeutic purposes.
Yes
Explanation: The device measures various ocular biometric parameters such as axial length, anterior chamber depth, lens thickness, and corneal thickness. These measurements are used by ophthalmologists to assess the structure of the eye, which is crucial for diagnosing various eye conditions and planning treatments (e.g., IOL power calculation for cataract surgery). This process of obtaining measurements for assessment and diagnosis aligns with the definition of a diagnostic device.
No
The device description explicitly states it contains hardware components, including a 10MHz A-probe, a 20MHz-pachymetric probe, and measuring units, which are integral to its function of transmitting and receiving ultrasound for measurements.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs are used to examine specimens derived from the human body. The description clearly states that the ODM-1000A/P is an ultrasonic measuring instrument that transmits ultrasound into the eye tissue and receives echoes. It directly interacts with the patient's eye to take measurements.
- The intended use is for ophthalmology to measure anatomical parameters of the eye. This is a direct measurement of physical characteristics within the living body, not an analysis of a biological sample taken from the body.
- The device description details the use of ultrasound probes to measure distances within the eye. This is an in-vivo measurement technique.
Therefore, the ODM-1000A/P is a medical device used for in-vivo measurement, not an in-vitro diagnostic device.
N/A
Intended Use / Indications for Use
The ODM-1000A/P intended used for ophthalmology to accurately measure the axial length (AL), anterior chamber depth (ACD), lens thickness (LT), and corneal thickness (CT).
The ODM-1000A intended used for ophthalmology to accurately measure the axial length (AL), anterior chamber depth (ACD), lens thickness (LT).
The ODM-1000P intended used for ophthalmology to accurately measure the corneal thickness (CT).
Indications for Use:
Ultrasound Imaging of the Eye Axial biometric parameter measurement of the Eye
Intended Use: Diagnostic ultrasound imaging
Product codes
90-IYO, ITN
Device Description
ODM-1000 A/P Biometer is an ultrasonic measuring instrument of pulse reflection. It contains two independent units: A-Mode Axis Biometric Parameter Measuring Unit and P-Mode Corneal Thickness Measuring Unit. It can be selected by user to configure:
ODM-1000A Ultrasonic A-Biometer (only for axial A biometry)
ODM-1000P Pachymeter (only for corneal thickness measurement)
The A-Biometer consists of a 10MHz A-probe and biometric unit. The axial biometry is the measurement for anterior chamber depth (ACD), lens thickness (LENS), vitreous length (VITR) and axial length (AL).
Corneal thickness Pachymeter consists of a 20MHz-pachymetric probe and the measuring unit. It is on the basis of the measurement of time interval between the anterior and post interface reflection wave to get the thickness of the cornea.
The ODM-1000A/P includes A-mode axial biometric parameter measurement and P-mode Corneal thickness measurement. Users can switch between these two modes through keyboard.
In A-mode, the 10MHz transducer transmits ultrasound into eye tissue and receives its echo reflected back by anterior chamber, lens and vitreum. Each length and their sum (AL) are calculated by measuring the time spent in different parts.
In P-mode, the 20MHz transducer transmits ultrasound into eye tissue and receives its echo reflected back by the anterior and post interface reflection pulse of the cornea, and then measure the time interval between two reflection pulse to get the thickness of the cornea.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Eye, cornea
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Non-clinical test:
Compliance Tests for ODM-1000A/P are as follows:
Safety Test (IEC 60601-1, Tested by TÜV)
EMC Test Report (IEC 60601-1-2, Tested by TÜV)
Acoustic output Test (FDA Guidance Document "Information for Manufacture Seeking Marketing Clearance of Diagnostic Ultrasound System and Transducers")
Biological Safety Test (ISO 10993, Tested by TÜV)
Clinical test:
Not required
Conclusions:
The ODM-1000A/P Ultrasonic Biometer/Pachymeter for Ophthalmology and The ODM-1000A Ultrasonic Biometer for Ophthalmology, The ODM-1000P Ultrasonic Pachymeter Are equivalent in safety and efficacy to the legally marketed predicate device.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1560 Ultrasonic pulsed echo imaging system.
(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
510(k) Premarket Notification Model ODM-1000A/P Ultrasonic Biometer/Pachymeter For Ophthalmology
Attachment 8
JAN 3 1 2007
7 K063472
510(k) SUMMARY
1) Submitter Information
Name: MEDA. Co., Ltd. Address: Room D, F3, Building C2, Xinmao Science Skill Park, Huayuan Industry Development Area, Tianjin, China
Phone: 86-22-83713808 Fax: 86-22-83713880
Contact person: Edward A. Kroll Spectre Solutions, Inc. 5905 Fawn Lane Cleveland, Ohio 44141 Phone: (440) 546-9810 Fax: (440) 546-9124
Data Prepared: September 16, 2006
2) Name of Device
Trade Name:
ODM-1000A/P Biometer ODM-1000A Ultrasonic A-Biometer ODM-1000P Ultrasonic Pachymeter
Common Name:
Ultrasound A/P Scan System for Ophthalmology Ultrasound A Scan for Ophthalmology Ultrasound Pachymeter ·
1
Classification Name: Ultrasonic Pulsed Echo Imaging System Regulation Number: 892.1560 Product Code: 90-IYO
1
3) Predicate Devices
Micro Medical Devices' PalmScan AP2000/A2000/P2000 Devices, K043287
4) Intended Use
The ODM-1000A/P intended used for ophthalmology to accurately measure the axial length (AL), anterior chamber depth (ACD), lens thickness (LT), and corneal thickness (CT).
The ODM-1000A intended used for ophthalmology to accurately measure the axial length (AL), anterior chamber depth (ACD), lens thickness (LT).
The ODM-1000P intended used for ophthalmology to accurately measure the corneal thickness (CT).
5) Device Description
ODM-1000 A/P Biometer is an ultrasonic measuring instrument of pulse reflection. It contains two independent units: A-Mode Axis Biometric Parameter Measuring Unit and P-Mode Corneal Thickness Measuring Unit. It can be selected by user to configure:
ODM-1000A Ultrasonic A-Biometer (only for axial A biometry)
ODM-1000P Pachymeter (only for corneal thickness measurement)
The A-Biometer consists of a 10MHz A-probe and biometric unit. The axial biometry is the measurement for anterior chamber depth (ACD), lens thickness (LENS), vitreous length (VITR) and axial length (AL).
Corneal thickness Pachymeter consists of a 20MHz-pachymetric probe and the measuring unit. It is on the basis of the measurement of time interval between the anterior and post interface reflection wave to get the thickness of the cornea.
6) Technological characteristics
a) Devices Description
The ODM-1000A/P includes A-mode axial biometric parameter measurement and P-mode Corneal thickness measurement. Users can switch between these two modes through keyboard.
2
In A-mode, the 10MHz transducer transmits ultrasound into eye tissue and receives its echo reflected back by anterior chamber, lens and vitreum. Each length and their sum (AL) are calculated by measuring the time spent in different parts.
In P-mode, the 20MHz transducer transmits ultrasound into eye tissue and receives its echo reflected back by the anterior and post interface reflection pulse of the cornea, and then measure the time interval between two reflection pulse to get the thickness of the cornea.
b) Performance Data
- Non-clinical test
Compliance Tests for ODM-1000A/P are as follows: Safety Test (IEC 60601-1, Tested by TÜV) EMC Test Report (IEC 60601-1-2, Tested by TÜV) Acoustic output Test (FDA Guidance Document "Information for Manufacture Seeking Marketing Clearance of Diagnostic Ultrasound System and Transducers" ) Biological Safety Test (ISO 10993, Tested by TÜV)
- Clinical test
Not required
- Conclusions
The ODM-1000A/P Ultrasonic Biometer/Pachymeter for Ophthalmology and The ODM-1000A Ultrasonic Biometer for Ophthalmology, The ODM-1000P Ultrasonic Pachymeter
Are equivalent in safety and efficacy to the legally marketed predicate device.
3
Image /page/3/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the top half of the circle. Inside the circle is a stylized image of an eagle with its wings spread, with three wavy lines below the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Edward A. Kroll President Meda, Ltd. 5905 Fawn Lane CLEVELAND OH 44141
JAN 3 1 2007
Re: K063472
Trade Name: Meda Model ODM 1000 A/P Ultrasonic Biometer for Ophthalmology Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic ultrasonic transducer Regulatory Class: II Product Code: IYO and ITN Dated: November 11, 2006 Received: December 5, 2006
Dear Mr. Kroll:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the Meda Model ODM 1000 A/P Ultrasonic Biometer for Ophthalmology, as described in your premarket notification:
Transducer Model Number
A-Scan (10MHz) A-Scan (20MHz)
Image /page/3/Picture/13 description: The image is a circular logo or emblem. The text "1906-2006" is at the top of the circle. The letters "FDA" are in the center of the circle in a bold font. The word "Centennial" is below the letters "FDA". There are three stars below the word "Centennial".
Protecting and Promoting Public Health
4
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.
The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:
Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html
5
If you have any questions regarding the content of this letter, please contact Andrew Kang, M.D.
- (240) 276, 2666 at (240) 276-3666.
Sincerely yours,
Nancy Brogdon
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure(s)
:
6
Indications for Use
510(k) Number (if known): 780
Device Name: Meda Model ODM 1000 A/P Ultrasonic Biometer for Ophthalmology
Indications for Use:
Indications for Use:
Ultrasound Imaging of the Eye Axial biometric parameter measurement of the Eye
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page of
(Posted November 13, 2003)
Nancy C. Brogdon
(Division Sign Off) Division of Reproductive, Abdomina and Radiological Devices 510(k) Number _
7
MEDA.CO., LTD.
Attachment 1
DIAGNOSTIC ULTRASOUND INDICATIONS FOR USE FORM
ODM-1000A/P & ODM-1000A, System: Transducer: __________________________________________________________________________________________________________________________________________________________________ A-Scan (10MHz)
Intended Use: Diagnostic ultrasound imaging K063472
| Clinical Application | Mode Of Operation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| A | B | M | PWD | CWD | Color Doppler | Amplitude Doppler | Color Velocity Imaging | Combined (specify) | Other* (Specify) | |
| Ophthalmic | N | |||||||||
| Fetal | ||||||||||
| Abdominal | ||||||||||
| Intraoperative (Specify) | ||||||||||
| Intraoperative Neurological | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) | ||||||||||
| Neuonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Cardicac | ||||||||||
| Transesophageal | ||||||||||
| transrectal | ||||||||||
| Transvaginal | ||||||||||
| Transurethral | ||||||||||
| Intravascular | ||||||||||
| Peripheral Vascular | ||||||||||
| Laparoscopic | ||||||||||
| Musculo-skeletal Conventional | ||||||||||
| Musculo-skeletal Superficial | ||||||||||
| Other (Specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Contents
Additional Contents: _________________________________________________________________________________________________________________________________________________________
(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of Center for Devices and Radiological Health, Office of Device Evaluation
Prescription Use (Per 21 CFR 801.109)
Vareus Broadon
(Division Sign Division of Reproductive, Pagearld Radiological Device 510(k) Number
8
DIAGNOSTIC ULTRASOUND INDICATIONS FOR USE FORM
ODM-1000A/P & ODM-1000P, System: Transducer: __________________________________________________________________________________________________________________________________________________________________
Intended Use: Diagnostic ultrasound imaging
Ko6347a
| Clinical Application | Mode Of Operation | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | M | PWD | CWD | Color | ||||||
| Doppler | Amplitude | ||||||||||
| Doppler | Color | ||||||||||
| Velocity | |||||||||||
| Imaging | Combined | ||||||||||
| (specify) | Other* | ||||||||||
| (Specify) | |||||||||||
| Ophthalmic | N | ||||||||||
| Fetal | |||||||||||
| Abdominal | |||||||||||
| Intraoperative (Specify) | |||||||||||
| Intraoperative Neurological | |||||||||||
| Pediatric | |||||||||||
| Small Organ (specify) | |||||||||||
| Neuonatal Cephalic | |||||||||||
| Adult Cephalic | |||||||||||
| Cardicac | |||||||||||
| Transesophageal | |||||||||||
| transrectal | |||||||||||
| Transvaginal | |||||||||||
| Transurethral | |||||||||||
| Intravascular | |||||||||||
| Peripheral Vascular | |||||||||||
| Laparoscopic | |||||||||||
| Musculo-skeletai | |||||||||||
| Conventional | |||||||||||
| Musculo-skeletal Superficial | |||||||||||
| Other (Specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Contents:
Pachymetric probe
(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of Center for Devices and Radiological Health, Office of Device Evaluation
Prescription Use (Per 21 CFR 801.109)
Nancy C. Hogdon
(Division Sigr dominal. Division of Reproductive, Al and Sedinlogical Devices 510(k) Number __
Page 2